Baker Biotech Capital III (GP), LLC Insider Trading $SGEN Seagen Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital III (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital III (GP), LLC. Baker Biotech Capital III (GP), LLC is 10% Owner in VIROPHARMA INC ($VPHM) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN).
Baker Biotech Capital III (GP), LLC in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital III (GP), LLC: Director
Holdings: 234,861 shares
Current Value: $14,277,200
Latest Transaction: May 06 2005
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital III (GP), LLC in Seagen Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, SGEN, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.79 | 6,305 | 30,199 | 234,861 | 228.6 K to 234.9 K (+2.76 %) |
| Apr 01 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.96 | 9,617 | 47,724 | 151,797 | 142.2 K to 151.8 K (+6.76 %) |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.90 | 5,276 | 25,848 | 142,180 | 136.9 K to 142.2 K (+3.85 %) |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.81 | 2,210 | 10,638 | 136,904 | 134.7 K to 136.9 K (+1.64 %) |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.90 | 719 | 3,523 | 134,694 | 134 K to 134.7 K (+0.54 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.96 | 63,330 | 314,085 | 133,975 | 70.6 K to 134 K (+89.65 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital III (GP) ... | Director | Buy | P | 4.99 | 46 | 230 | 70,645 | 70.6 K to 70.6 K (+0.07 %) |
Page: 1